Glucose plays a vital role in cell culture performance — directly impacting cell growth, viability, and product quality. Yet, real-time glucose control remains a blind spot in most upstream processes, with labs still relying on off-line or at-line measurements or complex spectroscopic systems

With its latest sensor innovation, Hamilton Process Analytics delivers a major leap forward: the first reusable, in-situ optical glucose sensor designed specifically for mammalian cell culture bioreactors.

Purpose-built for upstream bioprocessing, this groundbreaking technology offers:

• Real-time glucose insight from Day 1 — without multivariate models or laser safety concerns

• A robust, fiber-optic-free design, fully compatible with autoclave workflows

• Proven performance in fed-batch and perfusion CHO processes

• Seamless integration into existing PG 13.5 ports and digital/analog OT architectures (RS485, Modbus 4–20 mA)

Join this exclusive webinar to learn how this innovation is reshaping glucose control for scientists and engineers working in upstream bioprocessing.

• First session: November 26 - 9:30 am CET | 3:30 pm Standard China Time